BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 35755275)

  • 1. A mitochondria-targeting lipid-small molecule hybrid nanoparticle for imaging and therapy in an orthotopic glioma model.
    Tang M; Lin K; Ramachandran M; Li L; Zou H; Zheng H; Ma Z; Li Y
    Acta Pharm Sin B; 2022 Jun; 12(6):2672-2682. PubMed ID: 35755275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single Small Molecule-Assembled Mitochondria Targeting Nanofibers for Enhanced Photodynamic Cancer Therapy in Vivo.
    Lin K; Ma Z; Li J; Tang M; Lindstrom A; Ramachandran M; Zhu S; Lin TY; Zhang L; Li Y
    Adv Funct Mater; 2021 Mar; 31(10):. PubMed ID: 37441230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficient in vitro and in vivo docetaxel delivery mediated by pH-sensitive LPHNPs for effective breast cancer therapy.
    Jadon RS; Sharma G; Garg NK; Tandel N; Gajbhiye KR; Salve R; Gajbhiye V; Sharma U; Katare OP; Sharma M; Tyagi RK
    Colloids Surf B Biointerfaces; 2021 Jul; 203():111760. PubMed ID: 33872827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid-Polymer Hybrid Nanosystems: A Rational Fusion for Advanced Therapeutic Delivery.
    Jain S; Kumar M; Kumar P; Verma J; Rosenholm JM; Bansal KK; Vaidya A
    J Funct Biomater; 2023 Aug; 14(9):. PubMed ID: 37754852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EGF-functionalized lipid-polymer hybrid nanoparticles of 5-fluorouracil and sulforaphane with enhanced bioavailability and anticancer activity against colon carcinoma.
    Li S; Xu Z; Alrobaian M; Afzal O; Kazmi I; Almalki WH; Altamimi ASA; Al-Abbasi FA; Alharbi KS; Altowayan WM; Singh T; Akhter MH; Gupta M; Rahman M; Beg S
    Biotechnol Appl Biochem; 2022 Oct; 69(5):2205-2221. PubMed ID: 34775646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microfluidic fabrication and characterization of Sorafenib-loaded lipid-polymer hybrid nanoparticles for controlled drug delivery.
    Tahir N; Madni A; Li W; Correia A; Khan MM; Rahim MA; Santos HA
    Int J Pharm; 2020 May; 581():119275. PubMed ID: 32229283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functionalized Lipid-Polymer Hybrid Nanoparticles Mediated Codelivery of Methotrexate and Aceclofenac: A Synergistic Effect in Breast Cancer with Improved Pharmacokinetics Attributes.
    Garg NK; Tyagi RK; Sharma G; Jain A; Singh B; Jain S; Katare OP
    Mol Pharm; 2017 Jun; 14(6):1883-1897. PubMed ID: 28402673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methotrexate and beta-carotene loaded-lipid polymer hybrid nanoparticles: a preclinical study for breast cancer.
    Jain A; Sharma G; Kushwah V; Garg NK; Kesharwani P; Ghoshal G; Singh B; Shivhare US; Jain S; Katare OP
    Nanomedicine (Lond); 2017 Aug; 12(15):1851-1872. PubMed ID: 28703643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of pH-responsive dimethylglycine surface-modified branched lipids for targeted delivery of antibiotics.
    Makhathini SS; Omolo CA; Kiruri LW; Walvekar P; Devnarain N; Mocktar C; Govender T
    Chem Phys Lipids; 2022 Nov; 249():105241. PubMed ID: 36152880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-Delivery of Curcumin and Cisplatin to Enhance Cytotoxicity of Cisplatin Using Lipid-Chitosan Hybrid Nanoparticles.
    Khan MM; Madni A; Tahir N; Parveen F; Khan S; Jan N; Ali A; Abdurrahim M; Farooq U; Khan MI
    Int J Nanomedicine; 2020; 15():2207-2217. PubMed ID: 32280215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid poly (ɛ-caprolactone) hybrid nanoparticles of 5-fluorouracil for sustained release and enhanced anticancer efficacy.
    Khan S; Aamir MN; Madni A; Jan N; Khan A; Jabar A; Shah H; Rahim MA; Ali A
    Life Sci; 2021 Nov; 284():119909. PubMed ID: 34450169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paclitaxel-loaded solid lipid nanoparticles modified with Tyr-3-octreotide for enhanced anti-angiogenic and anti-glioma therapy.
    Banerjee I; De K; Mukherjee D; Dey G; Chattopadhyay S; Mukherjee M; Mandal M; Bandyopadhyay AK; Gupta A; Ganguly S; Misra M
    Acta Biomater; 2016 Jul; 38():69-81. PubMed ID: 27109765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Baicalin-Loaded Lipid-Polymer Hybrid Nanoparticles Inhibiting the Proliferation of Human Colon Cancer: Pharmacokinetics and In Vivo Evaluation.
    Riadi Y; Afzal O; Geesi MH; Almalki WH; Singh T
    Polymers (Basel); 2023 Jan; 15(3):. PubMed ID: 36771901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Near infrared fluorescent imaging of brain tumor with IR780 dye incorporated phospholipid nanoparticles.
    Li S; Johnson J; Peck A; Xie Q
    J Transl Med; 2017 Jan; 15(1):18. PubMed ID: 28114956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Self-assembly of porphyrin-grafted lipid into nanoparticles encapsulating doxorubicin for synergistic chemo-photodynamic therapy and fluorescence imaging.
    Hameed S; Bhattarai P; Liang X; Zhang N; Xu Y; Chen M; Dai Z
    Theranostics; 2018; 8(19):5501-5518. PubMed ID: 30555560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multifunctional-targeted nanoagent for dual-mode image-guided therapeutic effects on ovarian cancer cells.
    Chen C; Sun J; Chen S; Liu Y; Zhu S; Wang Z; Chang S
    Int J Nanomedicine; 2019; 14():753-769. PubMed ID: 30718954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of 188Re-labeled PEGylated nanoliposome as a radionuclide therapeutic agent in an orthotopic glioma-bearing rat model.
    Huang FY; Lee TW; Chang CH; Chen LC; Hsu WH; Chang CW; Lo JM
    Int J Nanomedicine; 2015; 10():463-73. PubMed ID: 25624760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymer-lipid-PEG hybrid nanoparticles as photosensitizer carrier for photodynamic therapy.
    Pramual S; Lirdprapamongkol K; Svasti J; Bergkvist M; Jouan-Hureaux V; Arnoux P; Frochot C; Barberi-Heyob M; Niamsiri N
    J Photochem Photobiol B; 2017 Aug; 173():12-22. PubMed ID: 28554072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and optimization of methotrexate-loaded lipid-polymer hybrid nanoparticles for controlled drug delivery applications.
    Tahir N; Madni A; Balasubramanian V; Rehman M; Correia A; Kashif PM; Mäkilä E; Salonen J; Santos HA
    Int J Pharm; 2017 Nov; 533(1):156-168. PubMed ID: 28963013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor microenvironment-activated cancer cell membrane-liposome hybrid nanoparticle-mediated synergistic metabolic therapy and chemotherapy for non-small cell lung cancer.
    Zhang W; Gong C; Chen Z; Li M; Li Y; Gao J
    J Nanobiotechnology; 2021 Oct; 19(1):339. PubMed ID: 34689761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.